While Novartis’ Pluvicto is a blockbuster, Curium heads into talks with the FDA about the review of its rival drug candidate ...
The FDA has placed a clinical hold on RGX-121 after small nodules or cystic masses were detected in the spines of five ...
The FDA has granted a three-month extension for Capricor Therapeutics’ Duchenne muscular dystrophy hopeful deramiocel in ...
The current classifications of vaccine recommendations could imply that not all shots require the consent of patients or ...
Not much is known about Boehringer Ingelheim’s drug candidate, dubbed BI 3031185, though the asset has completed at least two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results